Klaus Tomasz, Kulesza Małgorzata, Bzowska Monika, Wyroba Barbara, Kilarski Witold W, Bereta Joanna
Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Kraków, Gronostajowa 7, 30-387 Kraków, Poland.
Institute of Bioengineering and Swiss Institute for Cancer Research (ISREC), School of Life Sciences, SV-IBI-LLCB, Station 15, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Protein Expr Purif. 2015 Jun;110:151-8. doi: 10.1016/j.pep.2015.03.001. Epub 2015 Mar 7.
The first reports about successfully expressed recombinant proteins with the use of a baculovirus vector were published over 30years ago. Despite the long time of refining this expression system, early problems with the production of baculovirus-derived secretory proteins are still not satisfactorily solved. The high expression level driven by baculoviral promoters often does not result in the desired yield of secreted recombinant proteins, which frequently accumulate inside insect cells and are only partially processed. During our attempts to produce vascular endothelial growth factor C (VEGF-C) with the use of a baculovirus vector we also faced an inefficient secretion of the recombinant protein to culture medium. We were not able to improve the outcome and obtain an acceptable concentration of VEGF-C in the medium by changing the culture conditions or utilizing different signal peptides. However, as a significant amount of native VEGF-C was detected inside the baculovirus-infected cells, we developed a simple method to purify recombinant, glycosylated VEGF-C from a lysate of the cells. The presented results indicate that the lack of a secretory protein in the insect cell culture medium after baculovirus infection does not necessarily signify failure in the production of the protein. As demonstrated by us and contrary to generally accepted views, the lysate of baculovirus-infected cells may constitute a valuable source of the biologically active, secretory protein.
30多年前就发表了关于使用杆状病毒载体成功表达重组蛋白的首批报告。尽管对该表达系统进行了长时间的优化,但杆状病毒衍生的分泌蛋白生产方面的早期问题仍未得到令人满意的解决。杆状病毒启动子驱动的高表达水平往往无法产生预期产量的分泌型重组蛋白,这些蛋白常常在昆虫细胞内积累,且只有部分得到加工。在我们尝试使用杆状病毒载体生产血管内皮生长因子C(VEGF-C)的过程中,我们也面临重组蛋白向培养基分泌效率低下的问题。我们无法通过改变培养条件或使用不同的信号肽来改善结果并在培养基中获得可接受浓度的VEGF-C。然而,由于在杆状病毒感染的细胞内检测到大量天然VEGF-C,我们开发了一种从细胞裂解物中纯化重组糖基化VEGF-C的简单方法。呈现的结果表明,杆状病毒感染后昆虫细胞培养基中缺乏分泌蛋白并不一定意味着蛋白生产失败。正如我们所证明的,与普遍接受的观点相反,杆状病毒感染细胞的裂解物可能构成生物活性分泌蛋白的宝贵来源。